Skip to main content
TipRanks
Go Ultimate75% OFF

ARS Pharmaceuticals (SPRY) Q3 2025 Earnings Report

593 Followers

SPRY Q3 2025 EPS Results

Actual EPS
-$0.52
Consensus EPS
-$0.45
Beat/Miss
Missed by -$0.07
One Year Ago EPS
-$0.20

SPRY Q3 2025 Revenue Results

Actual Revenue
$32.50M
Expected Revenue
$28.67M
Beat/Miss
Beat by +$3.83M
YoY Revenue Growth
+1471.62%

Earnings Announcement Details

Quarter
Q3 2025
Date
11/10/2025
Time
Before Open
Conference Call
Monday, November 10, 2025
SPRY Upcoming Earnings

ARS Pharmaceuticals's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q3 2025 Earnings Call Audio

SPRY Q3 2025 Earnings Call
0:00 / 0:00

Q3 2025 Earnings Slide Deck

Q3 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

SPRY Earnings History

SPRY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.28--0.41――
Nov 05, 20262026 (Q3)-0.30-0.36-0.5230.77% (+0.16)
Aug 13, 20262026 (Q2)-0.48-0.63-0.46-36.96% (-0.17)
May 15, 20262026 (Q1)-0.52-0.61-0.35-74.29% (-0.26)
Mar 09, 20262025 (Q4)-0.43-0.410.48-185.42% (-0.89)
Nov 10, 20252025 (Q3)-0.45-0.52-0.2-160.00% (-0.32)
Aug 13, 20252025 (Q2)-0.46-0.46-0.13-253.85% (-0.33)
May 14, 20252025 (Q1)-0.34-0.35-0.11-218.18% (-0.24)
Mar 20, 20252024 (Q4)-0.240.48-0.07785.71% (+0.55)
Nov 13, 20242024 (Q3)-0.14-0.20-0.16-25.00% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed